Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous Close | 7.400 |
| Open | 7.400 |
| Bid | 7.510 x N/A |
| Ask | 7.650 x N/A |
| Day's Range | 7.370 - 7.870 |
| 52 Week Range | 5.740 - 21.250 |
| Volume | |
| Avg. Volume | 133,100 |
| Market Cap | 3.055B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.
© 2024 Yahoo. All rights reserved.